Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 9219756.
- Also identified by PMC identifier 1074154.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate whether antecedent cytomegalovirus (CMV) infections in patients with Guillain-Barré syndrome are associated with the presence of specific antiganglioside antibodies, acute phase serum samples from 130 patients with Guillain-Barré syndrome and 200 controls were tested. Anti-GM2 IgM antibodies were found more often in patients with Guillain-Barré syndrome with CMV infection (22%) than in patients without the infection (2%) (P = 0.003). CMV infections may elicit anti-GM2 antibodies in susceptible patients, which may contribute to the pathogenesis of Guillain-Barré syndrome associated with CMV.
Medical subject headings
- Cytomegalovirus Infections
- G(M2) Ganglioside
- Polyradiculoneuropathy